Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Anika Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ANIK
Nasdaq
2836
www.anika.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Anika Therapeutics, Inc.
PBYI's Alisertib Combo Phase II Study in Small Cell Lung Cancer Begins
- Sep 18th, 2026 8:48 am
RCKT Aligns With FDA on Completing Phase II Study in Danon Disease
- Sep 16th, 2026 8:56 am
Immunocore Hits Enrollment Target in Kimmtrak Label Expansion Study
- Sep 15th, 2026 9:22 am
Roche Gets FDA Priority Tag for Enspryng in Rare Autoimmune Disorder
- Sep 10th, 2026 9:42 am
Novartis' Del-desiran Fails Late-Stage DM1 Study, Shares Fall
- Sep 9th, 2026 12:47 pm
FDA Accepts & Gives Priority Review to Intellia's BLA for HAE Drug
- Sep 9th, 2026 8:05 am
ABBV's Etentamig Meets Goals in Phase III Multiple Myeloma Study
- Sep 4th, 2026 8:48 am
TEVA's TEV '408 Meets Goal in Phase IIa Celiac Disease Study
- Sep 3rd, 2026 9:23 am
QURE Submits Application for Gene Therapy for Huntington's Disease
- Sep 3rd, 2026 8:30 am
Novartis' Remibrutinib Delivers Positive Results in Late-Stage MS Studies
- Sep 2nd, 2026 12:29 pm
GSK to Advance mRNA Influenza Vaccine Into Phase III Development
- Sep 2nd, 2026 9:11 am
OCGN Advances Gene Therapy OCU410 In Phase III for Geographic Atrophy
- Sep 2nd, 2026 8:52 am
Axsome Begins Phase III Study on AXS-05 for Smoking Cessation
- Sep 1st, 2026 10:05 am
JAZZ Rises on Updated OS Results From Gastric Cancer Study
- Sep 1st, 2026 10:02 am
Teva Seeks to Boost Neuroscience Portfolio With BioXcel Asset Bid
- Aug 31st, 2026 9:36 am
ORKA Stock Up More Than 60% in 3 Months: Here's What You Should Know
- Aug 28th, 2026 9:10 am
Best Momentum Stocks to Buy for August 26th
- Aug 26th, 2026 8:00 am
J&J's Imaavy Gets FDA Approval as the First Treatment for wAIHA
- Aug 25th, 2026 10:10 am
Anika (ANIK) Is a Great Choice for 'Trend' Investors, Here's Why
- Aug 24th, 2026 6:55 am
Anika Stock Gains 43.4% in the Past 3 Months: Here Is Why?
- Aug 21st, 2026 9:39 am
Scroll